Early manifestations of nephropathy in alloxan-treated rats.
- 1 January 1998
- journal article
- research article
- Published by Taylor & Francis in Renal Failure
- Vol. 20 (4) , 551-564
- https://doi.org/10.3109/08860229809045147
Abstract
An early stage of diabetic nephropathy was studied. Rat renal function was evaluated by clearance techniques, 7 or 15 days after alloxan administration (groups A7 and A15). Significant diminutions of glomerular filtration rate (inulin clearance) and p-aminohippurate clearance were observed in alloxan-treated rats. Diabetic animals presented glucosuria and enhanced water excretion. A natriuretic response was only observed in A15-rats. Arterial pressure increased along time, and enlarged lipid deposits in glomeruli and vessels of A7-kidney sections were observed. Thus, a vascular compromise at this time was suggested. To better characterize the set up of the renal dysfunction, other studies were performed in A7-group. Urinary protein excretion remained unchanged while a higher level of glycosylation of urinary proteins was observed in A7-rats. Histological studies revealed a normal general morphology in kidneys from diabetic rats. Immunohistochemical analysis in renal sections showed enlarged deposits of fibronectin in glomeruli and interstitium of alloxan-treated rats. Higher myeloperoxidase activity was observed in renal cortex from diabetic animals indicating leukocytes infiltration. These results indicated that 7 days after hyperglycemia induction, the animals presented a renal dysfunction characterized by hemodynamic alterations associated with vascular and glomerular structural impairments, without modifications in tubular function. The higher level of protein glycosylation and the inflammatory process at this early stage could be responsible for the beginning of diabetic nephropathy.Keywords
This publication has 25 references indexed in Scilit:
- Prevention of glomerular hyperfiltration in rats with streptozotocin-induced diabetes by an atrial natriuretic peptide receptor antagonistDiabetologia, 1995
- The effects of streptozocin-induced diabetes on renal plasma flowExperimental and Clinical Endocrinology & Diabetes, 1995
- Long-Term Complications of Diabetes MellitusNew England Journal of Medicine, 1993
- Advanced Glycosylation End Products in Patients with Diabetic NephropathyNew England Journal of Medicine, 1991
- The implication of renal glutathione levels in mercuric chloride nephrotoxicityToxicology, 1989
- Rat kidney function related to tissue glutathione levelsBiochemical Pharmacology, 1986
- [20] Human myeloperoxidase and hemi-myeloperoxidasePublished by Elsevier ,1986
- Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy.Proceedings of the National Academy of Sciences, 1985
- A Colorimetric Assay for Glycoproteins Based on the Periodic Acid/Schiff StainBiochemical Society Transactions, 1978
- Simplified measurement of p-aminohippurate and other arylamines in plasma and urineKidney International, 1974